Please login to the form below

acquisitions

This page shows the latest acquisitions news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca reports ‘strong’ Q1 results, forecasts accelerated growth in 2021

AZ has also excluded its proposed acquisition of Alexion Pharmaceuticals from this guidance, adding in the Q1 results that Alexion will become its rare disease unit and an ‘area of expertise’. ... Sustained pipeline progress and accelerating business

Latest news

GSK’s revenue drops by 18% in Q1 as performance pressures mount

According to The Guardian, Elliott Management is an ‘aggressive activist’ investor – in the pharma industry, the hedge fund petitioned for the sale of Alexion Pharmaceuticals ahead of its subsequent acquisition by
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics

Drug could treat life-threatening antifungal-resistant infections. Pfizer has announced its acquisition of Amplyx Pharmaceuticals, gaining a phase 2 investigational asset for the treatment of invasive fungal infections in the ... We’ve already invested
GSK wins approval for anti-PD-1 antibody Jemperli in endometrial cancer

GSK acquired Jemperli as part of its $5.1bn acquisition of cancer specialist Tesaro, although the drug was initially developed by AnaptysBio.
Healthware Group acquires London-headquartered consultancy SWM

Acquisition follows years of collaboration between the two companies. SWM founders Genevieve Robson and Francis Mahmud Namouk. ... We are very excited about this acquisition, which further marks the commitment of Healthware in the next stage of evolution
Oxford University, Prenetics to advance COVID-19 rapid testing for other infectious diseases

The new collaboration follows Prenetics’ acquisition of Oxford University spinout COVID-19 testing company Oxsed last year. ... As part of its proposed acquisition of GenMark, Roche will add the company’s respiratory pathogen panels to its arsenal.

More from news
Approximately 198 fully matching, plus 1,253 partially matching documents found.

Latest Intelligence

Integrating competitive intelligence into business development, licensing and M&A strategy

In many circumstances, there is a need to make assessments of potential acquisition targets without the acquiree being aware of the initial interest. ... In the acquisition assessment process, the development of a TPP is a collaborative effort between
Back to the future

Equally, large firms have been slow to adapt both to new technologies and changing customer needs and have resorted to acquisition over organic evolution.
Transforming clinical trial data into a long-term asset

On the corporate side, it can come into play in licensing and partnership opportunities, in handling legal challenges and due diligence, and in mergers and acquisitions.
Sourcing R&D innovation: why pharma companies need to evolve their business models

the pipeline, the use of technology in medicine is expected to grow and so are the associated deals, mergers and acquisitions. ... They also can help identify collaboration opportunities including partnerships, licensing deals and merger or acquisition
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

Another example is Biogen’s $800m acquisition of Nightstar’s late-stage gene therapy assets for retinal disease – NSR-REP1 and NSR-RPGR.

More from intelligence
Approximately 75 fully matching, plus 95 partially matching documents found.

Latest appointments

Deborah Keller appointed as chair of Fishawack Health’s board

Keller’s appointment follows a number of recent acquisitions at Fishawack, including the healthcare marketing and scientific communications agency The Hive Health Group and the global market access consultancy PRMA Consulting.
New hires at FibroGen, Saniona and Turbine

In that role, Barge oversaw the company’s acquisition of Kudos, which yielded the drug Lynparza (olaparib).
New hires at Bristol-Myers Squibb, Acceleron and FerGene

Metcalfe joins BMS from CVS Health, where she led communications following the company’s acquisition of Aetna, where she was chief communication officer.
New hires at Abbott, Kite and Arrakis Therapeutics

Jude Medical – Abbott’s largest acquisition. He also led Abbott’s Diabetes Care business and the launch of the FreeStyle Libre. ... Most recently, Bosley served as the chief executive officer of Editas Medicine, and previously worked as CEO of
New hires at Bayer, Eisai and Accord Healthcare

Marianne De Backer is a recognised business leader with an impressive track record spanning over two decades in research and commercial, as well as licensing, mergers and acquisitions,” said Stefan Oelrich,

More from appointments
Approximately 0 fully matching, plus 120 partially matching documents found.

Latest from PMHub

Lucid Group is building its data analytics capability

You can find the most recent job openings on LinkedIn, or contact one of the talent acquisition managers, Dan or Lucinda..
Waterland-backed imc group progresses ambitious growth strategy with the addition of Indigo Medical

Waterland Private Equity Investment Director, Dominic Graham added, “We are pleased to support Shairose and imc group as they continue their expansion through organic growth and acquisitions.
Fishawack Health unveils an unrivaled global market access and HEOR offering with the acquisition of PRMA Consulting

The acquisition bolsters Fishawack Health’s strong strategic offering, adding deep expertise in Asia-Pacific and European markets to complement the company’s existing market access offering in North America. ... We’re delighted to welcome PRMA
Dovetail partners with Tillotts AG to map management of C. difficile infection in Europe

Specialist stakeholder engagement consultancy Dovetail, based in London, UK, have announced a new partnership with Tillotts Pharma AG to support the launch of Tillotts’ recent acquisition DIFICLIR in the EU.
Envision Pharma Group acquires doDOC to enable seamless document collaboration as part of iEnvision, its global medical affairs platform

London, UK, March 18, 2021. Envision Pharma Group (“Envision” or the “Company”), a leading global technology-enabled scientific communications company, is pleased to announce the acquisition of doDOC Corp., a leader ... Envision’s acquisition

More from PMHub
Approximately 10 fully matching, plus 89 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Head of Strategic Planning, Healthcare Advertising/ Brand comms,...: Six figure salary

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Editor & Senior Editor - Medical Communications - Home Based: Highly Competitive Salary, Bonus &Benefits

Group Account Director, Healthcare Advertising/ Brand comms, Lon...: 8 month contract up to £90K

Editorial Traffic Manager, Medical Communications Agency, London...: up to £45K

Publications Director: Competitive Salary

Senior Medical Writer: Competitive Salary

Senior & Principal Medical Writers Medical Communications - ...: Salary TBC

Account Manager - Creative Healthcare Communications - South Wes...: Excellent Remuneration

Senior Account Manager/ Account Director: Competitive Salary Offered

Senior & Principal Medical Writer: Competitive Salary Offered

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Senior Account Executive: Competitive Salary

Medical Editor: Competitive Salary

Medical Writers (All levels) Editorial / Scientific Leads & ...: Highly Competitive Remuneration packages

Senior Account Director & Associate Director - Healthcare Ad...: Highly Competitive Salary, Bonus &Benefits

Account Manager: Competitive Salary

Medical Writer, Senior Medical Writer, Principal Medical Writer,...: Highly Competitive Salary, Bonus &Benefits

Associate Account Director: Competitive Salary

Account Management: Competitive Salary Offered

Client Services Director – London or Home Based – Medical Commun...: Highly Competitive Salary, Bonus &Benefits

Home Working Medical Copy Writer & Senior Medical Copy Write...: Highly Competitive Salary, Bonus &Benefits

PMHub

Add my company

IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?: Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials: Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity: Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....

Email:
Password:

Please login to the form below

acquisitions

COVID-19 Updates and Daily News

Featured jobs

Quick links